Exploratory Study of CD10^low Polymorphonuclear Leukocytes Preceding and Correlating With Postsurgical Inflammation

Area of Science:

• Immunology
• Biomarker Discovery
• Surgical Complications

Background:

• Postsurgical immunological complications, like systemic inflammation, lack effective diagnostic tools, impacting patient outcomes.
• Reliable immune monitoring is crucial for managing post-surgery inflammatory responses.
• Polymorphonuclear leukocytes (PMNs), particularly immature CD10-low PMNs, are implicated in early postsurgical inflammation.

Purpose of the Study:

• To investigate the role of CD10-low PMNs as an early diagnostic marker for postsurgical inflammation.
• To explore the correlation between CD10-low PMN counts and established inflammatory markers and organ damage indicators.
• To compare the characteristics of CD10-low PMNs with mature CD10-high PMNs.

Main Methods:

• Non-interventional exploratory study involving patients undergoing cardiac surgery with extracorporeal circulation.
• Quantification of CD10-low PMNs released post-surgery.
• Measurement of fluid phase markers of inflammation (CRP, IL-6) and organ damage (NGAL, CK-MB, troponin-T).
• Comparative analysis of CD10-low and CD10-high PMN expression (CD11b) and platelet-neutrophil complex (PNC) formation.

Main Results:

• The number of CD10-low PMNs correlated with postsurgical inflammation and organ damage markers.
• CD10-low PMN levels increased significantly 24 hours earlier than established markers like CRP and IL-6.
• CD10-low PMNs exhibited lower CD11b expression and reduced formation of platelet-neutrophil complexes compared to CD10-high PMNs.

Conclusions:

• CD10-low PMNs represent a promising early cellular biomarker for assessing postsurgical inflammatory response.
• These immature PMNs may offer superior early detection of inflammation compared to current markers.
• CD10-low PMNs could facilitate rapid immune monitoring for excessive inflammation and organ impairment risk.